LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 47.93 | 27.76 | 3525 | 4421 | 0.7973 | 0.9390 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 49.63 | 27.76 | 253 | 4818 | 0.0525 | 0.3459 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 49.63 | 27.76 | 4976 | 4818 | 1.0328 | 1.0087 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 49.63 | 27.76 | 3322 | 4818 | 0.6895 | 0.9025 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 49.63 | 27.76 | 3664 | 4818 | 0.7605 | 0.9277 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 51.33 | 27.76 | 219 | 5117 | 0.0428 | 0.3158 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 51.33 | 27.76 | 5255 | 5117 | 1.0270 | 1.0071 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 51.33 | 27.76 | 3513 | 5117 | 0.6865 | 0.9025 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 51.33 | 27.76 | 3895 | 5117 | 0.7612 | 0.9288 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 53.04 | 27.76 | 280 | 5365 | 0.0522 | 0.3557 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 53.04 | 27.76 | 5582 | 5365 | 1.0403 | 1.0104 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 53.04 | 27.76 | 3619 | 5365 | 0.6745 | 0.8989 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 53.04 | 27.76 | 3992 | 5365 | 0.7440 | 0.9236 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 54.74 | 27.76 | 277 | 5606 | 0.0494 | 0.3504 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 54.74 | 27.76 | 5938 | 5606 | 1.0591 | 1.0151 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 54.74 | 27.76 | 3712 | 5606 | 0.6621 | 0.8952 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 54.74 | 27.76 | 4194 | 5606 | 0.7481 | 0.9256 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 56.45 | 27.76 | 271 | 5745 | 0.0472 | 0.3447 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 56.45 | 27.76 | 6269 | 5745 | 1.0911 | 1.0228 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 56.45 | 27.76 | 3957 | 5745 | 0.6887 | 0.9054 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 56.45 | 27.76 | 4406 | 5745 | 0.7669 | 0.9322 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 58.15 | 27.76 | 244 | 5906 | 0.0413 | 0.3246 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 58.15 | 27.76 | 6659 | 5906 | 1.1274 | 1.0312 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 58.15 | 27.76 | 3975 | 5906 | 0.6730 | 0.9002 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 58.15 | 27.76 | 4491 | 5906 | 0.7603 | 0.9304 | MN20160318_Q01 | M03 |